Please login or register to print this page.

News & Views

Browse all articles in News & Views

June 25, 2010

MADIT-CRT shows women have greater benefit from CRT-D’s

Recently announced results from a sub-analysis of the MADIT-CRT trial data that show that women receive a greater clinical benefit from cardiac resynchronization therapy defibrillators (CRT-Ds) than men. The results were presented during the 17th Cardiostim World Congress by Jonathan Steinberg, M.D., Chief of Cardiology and Director of the Al-Sabah Arrythmia Institute, St. Luke’s-Roosevelt Hospital Center, New York.

read more

June 10, 2010

Contrast-induced nephropathy (CIN) reduced with iodixanol

Results from the largest comparative, randomized clinical trial of patients who are at risk for contrast-induced nephropathy (CIN) demonstrate that VISIPAQUE™ (iodixanol), an iso-osmolar contrast medium, is associated with a significantly lower incidence of CIN in high-risk elderly patients, compared with low-osmolar iopromide, another commonly used contrast medium.

read more

June 10, 2010

Personalized medicine set to impact justice system

Enabled by pharmacogenomics, molecular imaging and other molecular biomarkers, personalized medicine promises to optimize modern medicine and minimize the potential side effects of therapeutic agents. A leading pathologist has now indicated that it may also dramatically impact the justice system, and in ways that we are only just beginning to understand.

read more

May 6, 2010

PCI- safety without surgical cover confirmed

PCI can be performed safely and with significant improvement at centres without a surgical service, according to a study published in the European Journal of Cardiovascular Prevention and Rehabilitation.
There is now little dispute that percutaneous coronary intervention (PCI) has revolutionised the management of patients with acute coronary events such as heart attack. Moreover, improvements in [...]

read more

May 6, 2010

The British Valve Group – a new special interest group

The influence and importance of valve disease is increasing and yet the subject remains under-represented.  There is, for example, no group affiliated to the British Cardiovascular Society and no National Services Framework on valve disease.   A number of interested individuals have recently convened to discuss the formation of a specialist group.
This might issue comments on [...]

read more

April 21, 2010

Large variations in medical cover in hospitals at night

Research carried out by the Royal College of Physicians (RCP) has identified large variations in the provision of medical cover at night, with some doctors being responsible for up to 400 patients.

read more

April 20, 2010

EU Rules On Working Weeks Leading To Higher Rates Of Sick Leave In Junior Doctors

A new study published today in Clinical Medicine, the journal of the Royal College of Physicians, shows that the European Working Time Directive (EWTD) may be failing in its primary objective – to improve the welfare of employees. A group of doctors have found a link between the introduction of rotas compliant with a 48-hour working week and increased prevalence and longer periods of sick leave in junior doctors.

read more

April 20, 2010

Study shows failure to lower cholesterol adequately

Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany in the European Heart Journal [1]. 


read more

April 20, 2010

Project investigates the arrhythmia-risks of antipsychotics and other medicines

A new multidisciplinary strategy will be applied to create a drug risk assessment, using anonymised medical data from more than 27 million European patients, to allow more informed treatment and decision making by clinicians in prescribing drugs.

read more

April 20, 2010

CLARITY trial looks at efficacy, safety and efficiency of catheter ablation of AF

Biosense Webster has announced that it has obtained its first Ethics Committee approval for the CLARITY study, comparing the 1-year efficacy, safety and efficiency of CARTO® 3 System-guided radiofrequency ablation using the NAVISTAR®

read more

« Newer articlesOlder articles »

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

PROUDLY SPONSORED BY

Sanofi-Aventis Medtronic Sanofi-Aventis Medtronic

ENDORSED BY

  • Arrhythmia Alliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.